Rhythm Pharmaceuticals Inc (RYTM)
38.28
+0.13
(+0.34%)
USD |
NASDAQ |
Apr 26, 16:00
38.31
+0.03
(+0.08%)
After-Hours: 20:00
Rhythm Pharmaceuticals Profit Margin (Quarterly): -171.8% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -171.8% |
| September 30, 2023 | -196.2% |
| June 30, 2023 | -243.0% |
| March 31, 2023 | -455.0% |
| December 31, 2022 | -483.4% |
| September 30, 2022 | -953.8% |
| Date | Value |
|---|---|
| June 30, 2022 | -496.4% |
| March 31, 2022 | -3.52K% |
| December 31, 2021 | -2.36K% |
| September 30, 2021 | -3.42K% |
| June 30, 2021 | -12.92K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.92K%
Minimum
Jun 2021
-171.8%
Maximum
Dec 2023
-2.29K%
Average
-496.4%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | -23.64% |
| Insmed Inc | -222.3% |
| Altimmune Inc | -85.52K% |
| Regeneron Pharmaceuticals Inc | 33.77% |
| Viking Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -89.34% |
| Return on Assets | -53.53% |
| Return on Invested Capital | -89.34% |
| Gross Profit Margin (Quarterly) | 86.66% |
| Operating Margin (Quarterly) | -170.3% |
| Return on Net Operating Assets | -631.3% |